-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/2024-tf-new-members-bulletin.pdf
January 01, 2024 - A recognized
researcher in hypertension management and medication adherence, Dr.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions
September 18, 2018 - cardiovascular disease risk, the metabolic syndrome, hypertension or hyperlipidemia diagnoses, and medication … Many trials required participants to demonstrate medication adherence, meet weight loss goals before … of trials for each drug or variability in outcome reporting. 1 The rate of trial completion in the medication … and placebo groups by 12 months, with 80% to 96% of participants experiencing an adverse event in the medication … The higher rate of adverse events in the medication groups resulted in higher dropout rates than in the
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/SkbkgyTc826aqUmKghKELw
July 01, 2023 - levels are available, including lifestyle modification (eg, changes in diet and physical
activity), medication
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
December 17, 2024 - Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication … Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication … a known disorder related to bone metabolism (e.g., osteoporosis or vitamin D deficiency) or taking medication
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ndk2qMLMrpq_DLV5ddEQFd
August 22, 2023 - • It is important that persons taking PrEP receive counseling about medication adherence and safer … , the CDC recom-
mends testing with both an HIV antigen-antibody assay and an HIV-1
RNA assay.11
Medication … for several reasons,
including personal preference, decreased risk of HIV acquisition, or
adverse medication … acquisition vs oral TDF/FTC (0.3% vs 2.3%; RR,
0.11 [95% CI, 0.04-0.31]).40
Harms of Preventive Medication … Medication
adherence in a nationwide cohort of veterans
initiating pre-exposure prophylaxis (PrEP)
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sDvjG49sFm7t3f3CnZUuFw
October 04, 2005 - out normal bereavement, a
history of a Manic Episode (Bipolar Disorder), and a physical disorder, medication
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/prediabetes-t2dm-bulletin.pdf
August 24, 2021 - Metformin, a diabetes medication, is also an effective intervention that may prevent or delay diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/GON-final-rs-bulletin.pdf
January 29, 2019 - The only medication approved by the U.S.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/hepatitis-b-pregnant-women-draft-rec-bulletin-updated.pdf
February 04, 2019 - with
hepatitis B from transmitting it to their baby, there is an effective vaccine and preventive medication
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/prediabetes-screening-newsbulletin.pdf
April 12, 2021 - Metformin, a diabetes medication, is also an effective intervention that may prevent or delay diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - With Aspirin Use
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … ethnicity, comorbidities (diabetes, liver disease, ulcer disease, and previous GI bleeding), and concurrent medication … A patient's willingness and ability to use a daily medication is another consideration for selecting … 0.85 (0.71–1.02)
Previous GI hospitalization (yes vs. no)
2.87 (2.46–3.35)
Medication … Range), y
Women, %
Diabetes, %
Current
Smokers, %
Aspirin Dose and Frequency
Co-Medication
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
November 01, 2013 - For women who are at increased risk for breast cancer and at low
risk for adverse medication effects, … For women who are at increased risk for
breast cancer and at low risk for adverse medication ef-
fects … Neither
medication significantly reduced the risk for ER-negative
breast cancer, noninvasive breast cancer … The USPSTF found adequate evidence of small to
moderate risk for medication-associated VTEs (depending … on age), as well as small to moderate risk for medication-
associated endometrial cancer with tamoxifen
-
www.uspreventiveservicestaskforce.org/uspstf/document/routine-vitamin-supplementation-to-prevent-cancer-update-of-the-evidence-from-randomized-controlled-trials-19992002/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
June 15, 2003 - Controlled Trials 1999-2002*
Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cardiovascular/aspirin-to-prevent-cardiovascular-disease-and-cancer
April 11, 2016 - Cardiovascular Events
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … risk factors (including a history of gastrointestinal bleeding, ulcers, or NSAID use), or concomitant medication
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - to Prevent Cancer
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … priori subgroups: age, sex, race/ethnicity, baseline cancer risk*, comorbidities†, and concomitant medication … priori subgroups: age, sex, race/ethnicity, baseline cancer risk*, comorbidities†, and concomitant medication
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/genital-herpes-screening
December 20, 2016 - Evidence from RCTs does not establish whether preventive antiviral medication for asymptomatic HSV-2 … For KQ4 (effects of antiviral medication on subclinical HSV-2 shedding), we included any outcome measure … We included 2 fair-quality RCTs (n = 129; range, 63-66) that compared daily preventive antiviral medication … Two RCTs compared the benefit of daily suppressive antiviral medication with placebo for preventing genital … Evidence from RCTs does not establish whether preventive antiviral medication for asymptomatic HSV-2
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/genital-herpes-screening-november-2016
December 20, 2016 - Evidence from RCTs does not establish whether preventive antiviral medication for asymptomatic HSV-2 … For KQ4 (effects of antiviral medication on subclinical HSV-2 shedding), we included any outcome measure … We included 2 fair-quality RCTs (n = 129; range, 63-66) that compared daily preventive antiviral medication … Two RCTs compared the benefit of daily suppressive antiviral medication with placebo for preventing genital … Evidence from RCTs does not establish whether preventive antiviral medication for asymptomatic HSV-2
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xA88A347Uk9kr-mAXtjKWZ
January 01, 2010 - The USPSTF strongly recommends prophylactic ocular topical medication for all
newborns against gonococcal … neonatorum has
become rare in the United States since the implementation of universal preventive
medication … • Appropriate treatment of gonorrhea infection and administration of prophylactic
medication to … concerning the harms of prophylactic
4
http://www.uspreventiveservicestaskforce.org/uspstf/uspsstds.htm
medication
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/lipidschilddraftrsbulletin.pdf
December 22, 2015 - In addition, the
potential harms of long-term use of cholesterol-lowering medication by children and
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
June 09, 2020 - ; RR, 0.73 [95% CI, 0.62 to 0.85]; ARD, –18% [95% CI, –26% to –10%], respectively) vs placebo or no medication … For KQ6 and KQ7, studies of preemptive naloxone prescribed in clinical settings as a rescue medication … Most trials of medication therapy were among adults with opioid use disorder due to heroin use and not … Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) tool for … A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted